Cardiomyopathy is frequently associated with septic shock, despite divergences in type and severity of cardiac alterations making difficult the management of these patients. Different studies have focused on the use of high-sensitivity troponin assays as a tool to early diagnose patients with suspected cardiovascular disease, since they have a higher efficiency for detecting myocardial necrosis than conventional assays [1]. Nevertheless, their predictive role in the diagnosis of myocardial dysfunction associated to septic shock remains controversial [2].
